Eder, A.-C.; Matthias, J.; Schäfer, M.; Schmidt, J.; Steinacker, N.; Bauder-Wüst, U.; Domogalla, L.-C.; Roscher, M.; Haberkorn, U.; Eder, M.;
et al. A New Class of PSMA-617-Based Hybrid Molecules for Preoperative Imaging and Intraoperative Fluorescence Navigation of Prostate Cancer. Pharmaceuticals 2022, 15, 267.
https://doi.org/10.3390/ph15030267
AMA Style
Eder A-C, Matthias J, Schäfer M, Schmidt J, Steinacker N, Bauder-Wüst U, Domogalla L-C, Roscher M, Haberkorn U, Eder M,
et al. A New Class of PSMA-617-Based Hybrid Molecules for Preoperative Imaging and Intraoperative Fluorescence Navigation of Prostate Cancer. Pharmaceuticals. 2022; 15(3):267.
https://doi.org/10.3390/ph15030267
Chicago/Turabian Style
Eder, Ann-Christin, Jessica Matthias, Martin Schäfer, Jana Schmidt, Nils Steinacker, Ulrike Bauder-Wüst, Lisa-Charlotte Domogalla, Mareike Roscher, Uwe Haberkorn, Matthias Eder,
and et al. 2022. "A New Class of PSMA-617-Based Hybrid Molecules for Preoperative Imaging and Intraoperative Fluorescence Navigation of Prostate Cancer" Pharmaceuticals 15, no. 3: 267.
https://doi.org/10.3390/ph15030267
APA Style
Eder, A.-C., Matthias, J., Schäfer, M., Schmidt, J., Steinacker, N., Bauder-Wüst, U., Domogalla, L.-C., Roscher, M., Haberkorn, U., Eder, M., & Kopka, K.
(2022). A New Class of PSMA-617-Based Hybrid Molecules for Preoperative Imaging and Intraoperative Fluorescence Navigation of Prostate Cancer. Pharmaceuticals, 15(3), 267.
https://doi.org/10.3390/ph15030267